human papillomavirus

HPV series completion lags among boysFindings of a recently published observational retrospective cohort study point to a need for increased efforts to improve timely completion of the human papillomavirus (HPV) vaccine series among boys.
Top ob/gyn stories of 20162016 was a year of change and new challenges. Find out what the top news stories of 2016 were.
Why aren’t pediatricians recommending HPV vaccination more strongly?In a recently published essay to address this question, the authors suggest that pediatricians may present human papillomavirus (HPV) vaccine as optional or less urgent than other adolescent vaccines because they do not often read or hear about their patients’ being affected by HPV-associated cancers, which generally strike older populations.
Should HPV screening intervals be extended for some women?A new study questions whether current HPV testing intervals can be extended for some. Plus: Can azithromycin prophylaxis prevent post infection in women who have undergone a cesarean?
Should women over 65 be screened for cervical cancer?A study questions the existing guidance saying only women over 65 years who have risk factors should be screened for cervical cancer. Also, do placental syndromes increase the risk of cardiovascular disease? Plus: A look at Gardisil 9's safety profile.
Zika on the ground: Clinical impact updateAn update on the Zika virus and its impact on your practice. And, a look at whether or not vaginal delivery increases risk of incontinence. Plus: What was the impact of the HPV vaccine on HPV rates?
ACIP updates vaccination guidelines for 2016The Advisory Committee on Immunization Practices (ACIP) has updated the federal immunization guidelines, including more nuances of the guidelines visually represented on the schedule to enhance clarity.
Boy’s papule develops lymphangitic streakA baffled mother brings her 14-year-old son for evaluation of an asymptomatic bump that appeared on the side of his right third finger 1 week ago.
Expanded age indication cleared for Gardasil 9 in malesFDA approved expanded age indication for Human Papillomavirus 9-valent Vaccine, Recombinant (Gardasil 9, Merck) in males.
Unexplored skin virus population revealedMost of our normal skin-resident viruses reside in our skin bacteria, but may affect health via their influence on the microbiome.